Clinical Trial Update: Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer

View source ↗

Summary

This clinical trial update describes a study using microarrays to identify risks of metastatic relapse, toxicity, and resistance to adjuvant chemotherapy in com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Angers | Conditions: Non-small Cell Lung Cancer | Status: UNKNOWN